Marcy L. Guerra, Ph.D. - Publications

Affiliations: 
2011 Medicinal Chemistry and Molecular Pharmacology Purdue University, West Lafayette, IN, United States 
Area:
Pharmacology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Li B, Orton D, Neitzel LR, Astudillo L, Shen C, Long J, Chen X, Kirkbride KC, Doundoulakis T, Guerra ML, Zaias J, Fei DL, Rodriguez-Blanco J, Thorne C, Wang Z, et al. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors. Science Signaling. 10. PMID 28655862 DOI: 10.1126/Scisignal.Aak9916  0.73
2017 Guerra ML, Kalwat MA, McGlynn K, Cobb MH. Sucralose activates an ERK1/2-ribosomal protein S6 signaling axis. Febs Open Bio. 7: 174-186. PMID 28174684 DOI: 10.1002/2211-5463.12172  0.767
2016 Pratt EP, Salyer AE, Guerra ML, Hockerman GH. Ca(2+) influx through L-type Ca(2+) channels and Ca(2+)-induced Ca(2+) release regulate cAMP accumulation and Epac1-dependent ERK 1/2 activation in INS-1 cells. Molecular and Cellular Endocrinology. 419: 60-71. PMID 26435461 DOI: 10.1016/J.Mce.2015.09.034  0.793
2015 Wauson EM, Guerra ML, Dyachok J, McGlynn K, Giles J, Ross EM, Cobb MH. Differential Regulation of ERK1/2 and mTORC1 Through T1R1/T1R3 in MIN6 Cells. Molecular Endocrinology (Baltimore, Md.). 29: 1114-22. PMID 26168033 DOI: 10.1210/Me.2014-1181  0.779
2014 Osborne JK, Guerra ML, Gonzales JX, McMillan EA, Minna JD, Cobb MH. NeuroD1 mediates nicotine-induced migration and invasion via regulation of the nicotinic acetylcholine receptor subunits in a subset of neural and neuroendocrine carcinomas. Molecular Biology of the Cell. 25: 1782-92. PMID 24719457 DOI: 10.1091/Mbc.E13-06-0316  0.485
2014 Guerra ML, Wauson EM, McGlynn K, Cobb MH. Muscarinic control of MIN6 pancreatic β cells is enhanced by impaired amino acid signaling. The Journal of Biological Chemistry. 289: 14370-9. PMID 24695728 DOI: 10.1074/Jbc.M114.565069  0.766
2014 Wang Y, Jarrard RE, Pratt EP, Guerra ML, Salyer AE, Lange AM, Soderling IM, Hockerman GH. Uncoupling of Cav1.2 from Ca(2+)-induced Ca(2+) release and SK channel regulation in pancreatic β-cells. Molecular Endocrinology (Baltimore, Md.). 28: 458-76. PMID 24506535 DOI: 10.1210/Me.2013-1094  0.758
2013 Wauson EM, Guerra ML, Barylko B, Albanesi JP, Cobb MH. Off-target effects of MEK inhibitors. Biochemistry. 52: 5164-6. PMID 23848362 DOI: 10.1021/Bi4007644  0.754
2013 Jarrard RE, Wang Y, Salyer AE, Pratt EP, Soderling IM, Guerra ML, Lange AM, Broderick HJ, Hockerman GH. Potentiation of sulfonylurea action by an EPAC-selective cAMP analog in INS-1 cells: comparison of tolbutamide and gliclazide and a potential role for EPAC activation of a 2-APB-sensitive Ca2+ influx. Molecular Pharmacology. 83: 191-205. PMID 23071106 DOI: 10.1124/Mol.112.081943  0.742
2012 Wauson EM, Zaganjor E, Lee AY, Guerra ML, Ghosh AB, Bookout AL, Chambers CP, Jivan A, McGlynn K, Hutchison MR, Deberardinis RJ, Cobb MH. The G protein-coupled taste receptor T1R1/T1R3 regulates mTORC1 and autophagy. Molecular Cell. 47: 851-62. PMID 22959271 DOI: 10.1016/J.Molcel.2012.08.001  0.725
2009 Jacobo SM, Guerra ML, Hockerman GH. Cav1.2 and Cav1.3 are differentially coupled to glucagon-like peptide-1 potentiation of glucose-stimulated insulin secretion in the pancreatic beta-cell line INS-1. The Journal of Pharmacology and Experimental Therapeutics. 331: 724-32. PMID 19710366 DOI: 10.1124/Jpet.109.158519  0.785
2009 Jacobo SM, Guerra ML, Jarrard RE, Przybyla JA, Liu G, Watts VJ, Hockerman GH. The intracellular II-III loops of Cav1.2 and Cav1.3 uncouple L-type voltage-gated Ca2+ channels from glucagon-like peptide-1 potentiation of insulin secretion in INS-1 cells via displacement from lipid rafts. The Journal of Pharmacology and Experimental Therapeutics. 330: 283-93. PMID 19351867 DOI: 10.1124/Jpet.109.150672  0.683
2007 Porchia LM, Guerra M, Wang YC, Zhang Y, Espinosa AV, Shinohara M, Kulp SK, Kirschner LS, Saji M, Chen CS, Ringel MD. 2-amino-N-{4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p21-activated kinase. Molecular Pharmacology. 72: 1124-31. PMID 17673571 DOI: 10.1124/Mol.107.037556  0.382
Show low-probability matches.